Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Emery

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Trials|July 16, 2021
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trialShakira Milton, Jennifer McIntosh, Finlay Macrae, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
Pathology|May 3, 2025
Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophyEdwin Kirk, Linda Mundy, Eric Lee, et al.
Eclinicalmedicine|February 25, 2025
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trialRaymond J Chan, Fiona Crawford-Williams, Chad Yixian Han, et al.
BJGP Open|December 20, 2018
Development of an intervention to expedite cancer diagnosis through primary care: a protocolMarian Andrei Stanciu, Rebecca-Jane Law, Sadia Nafees, et al.
BMJ Open|June 19, 2025
Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trialRaymond J Chan, Fiona Crawford-Williams, Bogda Koczwara, et al.
BJGP Open|November 14, 2025
The sensitivity of decision support tools for identifying patients with pancreatic cancerRachel E Neale, Susan J Jordan, Bridie Thompson, et al.
Trials|September 24, 2025
The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver diseaseLeon A Adams, Deborah de Guingand, Gary P Jeffrey, et al.
Trials|May 19, 2023
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary careSibel Saya, Patty Chondros, Anastasia Abela, et al.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Trials|July 16, 2021
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trialShakira Milton, Jennifer McIntosh, Finlay Macrae, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
Pathology|May 3, 2025
Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophyEdwin Kirk, Linda Mundy, Eric Lee, et al.
Eclinicalmedicine|February 25, 2025
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trialRaymond J Chan, Fiona Crawford-Williams, Chad Yixian Han, et al.
BJGP Open|December 20, 2018
Development of an intervention to expedite cancer diagnosis through primary care: a protocolMarian Andrei Stanciu, Rebecca-Jane Law, Sadia Nafees, et al.
BMJ Open|June 19, 2025
Implementation and effectiveness of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study): protocol for a stepped-wedge cluster randomised trialRaymond J Chan, Fiona Crawford-Williams, Bogda Koczwara, et al.
BJGP Open|November 14, 2025
The sensitivity of decision support tools for identifying patients with pancreatic cancerRachel E Neale, Susan J Jordan, Bridie Thompson, et al.
Trials|September 24, 2025
The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver diseaseLeon A Adams, Deborah de Guingand, Gary P Jeffrey, et al.
Trials|May 19, 2023
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary careSibel Saya, Patty Chondros, Anastasia Abela, et al.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
Pageof 23